Gilead Opens $11-Million Manufacturing Facility QC LabBy
Gilead Sciences has opened a new EUR 9.5 million ($11-million) manufacturing facility quality-control (QC) laboratory in Carrigtwohill, County Cork, Ireland.
The company said that during the last five years, manufacturing of 11 Gilead products has been transferred to the Carrigtwohill plant, resulting in an increase in QC testing requirements. The manufacturing site primarily focuses on production of Gilead’s drugs to treat hepatitis and HIV.
Gilead acquired the Cork site in 2007 from Nycomed, a Zurich, Switzerland-based pharmaceutical company owned by Takeda at that time. The site is responsible for a quarter of Gilead’s total production of drugs in tablet form. Since the acquisition, the company has invested more than $229 million in the site, and the plant’s workforce has grown from 60 employees to 390.
Source: Gilead Sciences